Navigation Links
Transgenomic Reports Second Quarter 2008 Results
Date:8/5/2008

$0.00 $0.00 $0.00 $(0.02)

BASIC WEIGHTED

AVERAGE SHARES

OUTSTANDING 49,189,672 49,189,672 49,189,672 49,189,672

DILUTED WEIGHTED

AVERAGE SHARES

OUTSTANDING 49,301,010 49,189,672 49,301,010 49,189,672

Transgenomic, Inc.

Summary Financial Results

Unaudited Condensed Consolidated Statements of Cash Flows

(dollars in thousands)

Six Months Ended

June 30,

2008 2007

NET CASH FLOWS PROVIDED BY (USED IN)

OPERATING ACTIVITIES 193 (1,564)

NET CASH FLOWS PROVIDED BY (USED IN)

INVESTING ACTIVITIES (131) 3,572

EFFECT OF FOREIGN CURRENCY EXCHANGE

RATE CHANGES ON CASH (93) 7

NET CHANGE IN CASH AND CASH EQUIVALENTS (31) 2,015

CASH AND CASH EQUIVALENTS AT BEGINNING

OF PERIOD 5,723 5,868

CASH AND CASH EQUIVALENTS AT END OF PERIOD $5,692 $7,883

Transgenomic, Inc.

Summary Financial Results

Condensed Consolidated Balance Sheets

(dollars in thousands)

(Unaudited)

June 30, December 31,

2008 2007

ASSETS

CURRENT ASSETS:

Cash and cash equivalents $5,692 $5,723

Accounts receivable (net of all
'/>"/>

SOURCE Transgenomic
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast
3. Transgenomic, Inc. Forms Scientific Advisory Board
4. Transgenomic Appoints David Pauluzzi to Board of Directors
5. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
6. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
7. Transgenomic Opens Pharmacogenomics Laboratory in China
8. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
9. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
10. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
11. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiophar...zingnovelpainmanagementtherapies,announcedtodaytha...isscheduledtopresentatthe21stAnnualPiperJaffrayHea...YorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTonno...ailabletorespondtoquestionsduringthepresentationsa...
(Date:11/24/2009)...rbleEnergyCorp.announcedtodaythatthecompanyandtheO...warded$2millionbyWashingtonState,sCommunityEconomi...shiptoconstructthestate,sfirstspecialtybiochemical...ntwillsignificantlyspeedthedevelopmentofourbiorefi...ueMarbleEnergyCEOKellyOgilvie."WearegratefultotheG...
(Date:11/24/2009)...orpatientswithadvanced-stage,orrecurrentendometria...Call/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(t...donendocrinetherapyandoncology,todayannouncedposit...toxicpeptideconjugate,AEZS-108(formerlyAN-152),inp...apersonalizedhealthcareapproach,thestudyselectedpa...
(Date:11/24/2009)...Call/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobal...hatithassubmittedaMAAtotheEuropeanMedicinesAgencyf...therapyindevelopment,forthetreatmentofType1Gaucher...glucerasealfathathasbeensubmitted,withprevious,sub...aglobalsupplyshortageofthecurrentlyapprovedandmark...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
... Now Treat 100 Percent of Improvable Hearing-Impai...ENIX, July 28 As a promise to his daughter, Zound...eveloping the patented,technology behind Zounds Z1...ed price-point and overall comfort is now availabl...ing Aid released this month., (Photo: http://www...
...ientists at the University of Pennsylvania have cr...tion of functional nanoscale patterns or motifs wi...gle master "plate." , Researchers took advantage...ible polymer membrane, polydimethylsiloxane, or PD...the membrane elliptically deform, and elastic inte...
...008 Conference and Awards Celebration has show of ... PITTSBURGH, July 25 With the life sciences posit...ding an advantage amidst global,competition requir...2BUSINESS 2008 Conference and Awards Celebration, ...t edge., The inaugural event will draw some 100 s...
Other Biology Technology:Zounds Hearing Develops and Releases Power BTE Hearing Aid 2Zounds Hearing Develops and Releases Power BTE Hearing Aid 3Penn researchers demonstrate a flexible, 1-step assembly of nanoscale structures 2Penn researchers demonstrate a flexible, 1-step assembly of nanoscale structures 3Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 3
(Date:11/26/2009)...eir impressive antlers, red deer have been caught ...,s antlers are much more than decorative. They are...lling. John Currey, from The University of York, U... of bone for over half a century and has become fa...rough a long-standing collaboration with Tomas Lan...
(Date:11/26/2009)...llin-resistant Staphylococcus Aureus ) and other ... low-temperature plasma prototype devices have bee...ng bactericidal cocktails. , Two prototype devic...tion of healthy skin (e.g. hands and feet) in hosp...lethal threat; and another to shoot bacteria-killi...
(Date:11/25/2009)...arisch, Head of the Cell Death Research Laboratory...y, has been awarded the prestigious Johnson & John...ng the cause of brain cell damage in Parkinson,s d...cientists in support of innovation and excellence ...conferred earlier this month at an event at the Hy...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Environmental health chief in Milwaukee to hear citizen concerns 10107 1Environmental health chief in Milwaukee to hear citizen concerns 10107 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 1Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 3New Hope for Treatment of Pancreatic Cancer 58340 1New Hope for Treatment of Pancreatic Cancer 58340 2
...grow plant material and burn it. If managed well m... will be captured by the growing plants, and so ha...arbon dioxide. , Better still, the growing plants...roblems. In a review of current systems, Gran Bern...at Chalmers University of Technology in Gtenborg, ...
... flown to Mongolia the past three summers to searc...ld crew have joined him at Montana State Universit...n paleontologists. , Horner is Ameya Preserve cur...s and Regents Professor of Paleontology in Montana...eontology to be developed better," said Bolortsets...
...fference in the way males and females respond to c...plain why men are more prone to liver cancer, acco...nome-wide study that helps explain why there is su...e organ, where you wouldn,t expect to see one, sai...d lead author of a paper that appeared last month ...
Other Biology News:Biomass production -- careful planning can bring many benefits 2Mongolian paleontologists with a dream come to Montana State University 2Mongolian paleontologists with a dream come to Montana State University 3MIT: Why men are more prone to liver cancer 2
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
Mouse Anti-HLA DQ1, HLA DQ3 Monoclonal Antibody, Unconjugated, Clone HL-37 from Abcam
T4 DNA Ligase (HC) from Invitrogen
Biology Products: